Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.370
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST - Market closed

Mural Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-153.78-207.45-189.81-175.43
Depreciation & Amortization
3.262.571.541.47
Stock-Based Compensation
19.6524.1111.9311.5
Change in Accounts Payable
-6.55-18.258.395.52
Change in Other Net Operating Assets
-3.284.77-0.640.27
Operating Cash Flow
-139.5-194.25-168.59-156.67
Capital Expenditures
-1.25-3.45-5.51-4.39
Investing Cash Flow
-62.72-3.45-5.51-4.39
Other Financing Activities
315.01468.81174.1161.05
Financing Cash Flow
315.21468.81174.1161.05
Net Cash Flow
112.99271.11--
Free Cash Flow
-140.75-197.7-174.1-161.05
Free Cash Flow Per Share
-8.35-11.85-10.43-
Levered Free Cash Flow
-77.71-112.89-99.81-
Unlevered Free Cash Flow
-77.71-112.89-99.81-
Change in Net Working Capital
4.2614.47-7.81-
Source: S&P Capital IQ. Standard template. Financial Sources.